{"id":829377,"date":"2025-03-25T08:07:58","date_gmt":"2025-03-25T12:07:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/"},"modified":"2025-03-25T08:07:58","modified_gmt":"2025-03-25T12:07:58","slug":"akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/","title":{"rendered":"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., March  25, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=avrG8HlvlousOMYu5JL9rdEx6MWyQn1e0IVGMS2XXmDQkdAzHUcdKi-L42gtyCtHxA_FC7xLALUyARenlFJZveTpJdk46LgY2PC168yZHEM=\" rel=\"nofollow\" target=\"_blank\">Akebia Therapeutics<sup>\u00ae<\/sup>, Inc.<\/a> (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7snYyJgnAWykeUf0pHH-MfBKf4KVLZmXo17yrwW1qoySDiv7astpZoZI5cEWlPUJFea6PPL1iTraeIhjN704tUHQt6bcQC44yEbU47Cu6K7iEmntXWR7NDjI3OahHmjkta0rxaHYTQLI5gNo7uLw31L_YYyd2HWirXMTIks_2mA=\" rel=\"nofollow\" target=\"_blank\">National Kidney Foundation Spring Clinical Meetings 2025<\/a> (NKF SCM25), which will take place in Boston, MA from April 10-13, 2025.<\/p>\n<p>Akebia-supported posters will be displayed at NKF SCM25 during Exhibit Hall hours.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:0.1pt\">\n          <strong>Cardiovascular Risk in Patients With DD-CKD Randomized to Vadadustat vs Darbepoetin Alfa With or Without Cardiovascular Disease<\/strong>: <a href=\"https:\/\/cme.kidney.org\/spa\/app\/resource\/r649-2025-spring-clinical-meetings\/event\/home\/posters\/abstracts?abstractId=7124\" rel=\"nofollow\" target=\"_blank\">Poster: G-284 <\/a><\/p>\n<\/li>\n<li style=\"margin-bottom:0.1pt\">\n          <strong>Vadadustat for Treatment of Anemia in Older vs Younger Patients With Dialysis-Dependent-CKD<\/strong>: <a href=\"https:\/\/cme.kidney.org\/spa\/app\/resource\/r649-2025-spring-clinical-meetings\/event\/home\/posters\/abstracts?abstractId=7138\" rel=\"nofollow\" target=\"_blank\">Poster: G-285<\/a><\/li>\n<\/ul>\n<p>On Thursday, April 10, 2025 at 4:00 pm during <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ENK9Yg_AYUFVwit9lbphkeAoiDceaKyReRFRU00Nh1Ljvn2CiF0df6TJ3vcb-5JN6uUWboL8UvwEsJNZgro-n_CulQathuaDp7kMICc6KIIo8hkiM1qzeWQlK0Yz0xRRMZRsb_5_sHzguMruJPxiWGL4ngwfViLOLMCdwvCGF1QQ4bGJQo7NF4y4dzsY3g-Ou6Qj2DdG79_0tIPQ399dRhA7dTYvcSK7nnLe8AcPPfM=\" rel=\"nofollow\" target=\"_blank\">Oral Poster Presentation: Research 3<\/a> at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled \u201cVadadustat for Treatment of Anemia in Older vs Younger Patients With Dialysis-Dependent-CKD.\u201d<\/p>\n<p>NKF SCM25 attendees can also visit Akebia at Booth #1121 in the Exhibit Hall.<\/p>\n<p>\n        <strong>About Akebia Therapeutics<\/strong><br \/>\n        <br \/>Akebia Therapeutics, Inc.\u00a0is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in\u00a0Cambridge, Massachusetts. For more information, please visit our website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vFn_etpJ6vg1avhI-phVu5y1FhjSOQOggOV4PwYcEr1UytvwMhm74qUfoUX0u1qDprz6Wm9l08BwRMztG2EpUKMYxSgnDQ1BAkJQhZ4kRcM_assaKRG6i7BiU2Nr-YV79i5sc4VKvZTuhAtNeUSHpyWD9jEvez24SoaPaxlGfMn_xP8RxnNtIWGrW1_A4lvHNCMDhmKMSWVc1MRWRxac-w==\" rel=\"nofollow\" target=\"_blank\">www.akebia.com<\/a>, which does not form a part of this release.<\/p>\n<p>\n        <strong>Akebia Therapeutics Contact<\/strong><br \/>\n        <br \/>Mercedes Carrasco<br \/>mcarrasco@akebia.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWRmM2Q0YTYtNjA4ZC00MWE0LTg4OTUtYTgxMTY1YTBlNzNiLTEwMTc5MjgtMjAyNS0wMy0yNS1lbg==\/tiny\/Akebia-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) &#8212; Akebia Therapeutics\u00ae, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25), which will take place in Boston, MA from April 10-13, 2025. Akebia-supported posters will be displayed at NKF SCM25 during Exhibit Hall hours. Cardiovascular Risk in Patients With DD-CKD Randomized to Vadadustat vs Darbepoetin Alfa With or Without Cardiovascular Disease: Poster: G-284 Vadadustat for Treatment of Anemia in Older vs Younger Patients With Dialysis-Dependent-CKD: Poster: G-285 On Thursday, April 10, 2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-829377","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) &#8212; Akebia Therapeutics\u00ae, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25), which will take place in Boston, MA from April 10-13, 2025. Akebia-supported posters will be displayed at NKF SCM25 during Exhibit Hall hours. Cardiovascular Risk in Patients With DD-CKD Randomized to Vadadustat vs Darbepoetin Alfa With or Without Cardiovascular Disease: Poster: G-284 Vadadustat for Treatment of Anemia in Older vs Younger Patients With Dialysis-Dependent-CKD: Poster: G-285 On Thursday, April 10, 2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, &hellip; Continue reading &quot;Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-25T12:07:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025\",\"datePublished\":\"2025-03-25T12:07:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/\"},\"wordCount\":217,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/\",\"name\":\"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=\",\"datePublished\":\"2025-03-25T12:07:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/","og_locale":"en_US","og_type":"article","og_title":"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - Market Newsdesk","og_description":"CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) &#8212; Akebia Therapeutics\u00ae, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25), which will take place in Boston, MA from April 10-13, 2025. Akebia-supported posters will be displayed at NKF SCM25 during Exhibit Hall hours. Cardiovascular Risk in Patients With DD-CKD Randomized to Vadadustat vs Darbepoetin Alfa With or Without Cardiovascular Disease: Poster: G-284 Vadadustat for Treatment of Anemia in Older vs Younger Patients With Dialysis-Dependent-CKD: Poster: G-285 On Thursday, April 10, 2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, &hellip; Continue reading \"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-25T12:07:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025","datePublished":"2025-03-25T12:07:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/"},"wordCount":217,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/","name":"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=","datePublished":"2025-03-25T12:07:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQwOTkzMyM2ODMxNTY4IzIwMDYzNTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/akebia-therapeutics-announces-poster-presentations-at-nkf-spring-clinical-meetings-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=829377"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829377\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=829377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=829377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=829377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}